申请人:AbbVie S.à.r.l.
公开号:US20190315687A1
公开(公告)日:2019-10-17
The invention discloses compounds of Formula (I)
wherein R
1
, R
2
, R
2A
, R
3
, R
3A
, R
4
, and R
5
are as defined herein. The present invention relates to compounds and their use in the treatment of cystic fibrosis, methods for their production, pharmaceutical compositions comprising the same, and methods of treating cystic fibrosis by administering a compound of the invention.
本发明公开了式(I)化合物,其中R1、R2、R2A、R3、R3A、R4和R5如本文所定义。本发明涉及这些化合物及其在囊性纤维化的治疗中的应用,用于它们的生产的方法,包含这些化合物的制药组合物,以及通过给予本发明化合物治疗囊性纤维化的方法。